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Abstract
Purpose This review evaluates the current and future
role of cardiopulmonary exercise testing (CPET) in the
context of Enhanced Recovery After Surgery (ERAS)
programs.
Principal findings There is substantial literature
confirming the relationship between physical fitness and
perioperative outcome in general. The few small studies in
patients undergoing surgery within an ERAS program
describe less fit individuals having a greater incidence of
morbidity and mortality. There is evidence of increasing
adoption of perioperative CPET, particularly in the UK.
Although CPET-derived variables have been used to guide
clinical decisions about choice of surgical procedure and
level of perioperative care as well as to screen for
uncommon comorbidities, the ability of CPET-derived
variables to guide therapy and thereby improve outcome
remains uncertain. Recent studies have reported a
reduction in CPET-defined physical fitness following
neoadjuvant therapies (chemo- and radio-therapy) prior
to surgery. Preliminary data suggest that this effect may be
associated with an adverse effect on clinical outcomes in
less fit patients. Early reports suggest that CPET-derived
variables can be used to guide the prescription of exercise
training interventions and thereby improve physical fitness
in patients prior to surgery (i.e., prehabilitation). The
impact of such interventions on clinical outcomes remains
uncertain.
Conclusions Perioperative CPET is finding an
increasing spectrum of roles, including risk evaluation,
collaborative decision-making, personalized care,
monitoring interventions, and guiding prescription of
prehabilitation. These indications are potentially of
importance to patients having surgery within an ERAS
program, but there are currently few publications specific
to CPET in the context of ERAS programs.
Re´sume´
Objectif Cette e´tude e´value le roˆle actuel et dans le futur
des tests d’efforts cardiopulmonaires (CPET) dans le
contexte des programmes de re´cupe´ration rapide apre`s la
chirurgie (RRAC).
Constatations principales Il existe une abondante
litte´rature confirmant les rapports entre la forme
physique et l’e´volution ge´ne´rale du patient en pe´riode
pe´riope´ratoire. Les quelques petites e´tudes mene´es avec
des patients subissant une chirurgie dans un programme de
RRAC indiquent que les individus les moins en forme ont
une plus grande incidence de morbidite´ et mortalite´. Il
existe des donne´es probantes sur l’adoption croissante du
CPET pe´riope´ratoire, en particulier au Royaume-Uni. Bien
que des variables tire´es du CPET aient e´te´ utilise´es pour
guider les de´cisions cliniques sur le choix de la proce´dure
chirurgicale et le niveau de soins pe´riope´ratoires, ainsi que
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pour de´pister des comorbidite´s rares, la capacite´ des
variables tire´es du CPET pour guider le traitement et, par
conse´quent, ame´liorer ses re´sultats reste incertaine. Des
e´tudes re´centes ont de´crit une baisse de la forme physique
(de´finie par le CPET) apre`s des traitements ne´oadjuvants
(chimio et radiothe´rapie) pre´ce´dant une intervention
chirurgicale. Les donne´es pre´liminaires sugge`rent que
cela peut eˆtre associe´ a` un effet secondaire sur les re´sultats
cliniques des patients ayant la moins bonne condition
physique. De premiers rapports sugge`rent que les variables
tire´es du CPET peuvent eˆtre utilise´es pour guider la
prescription d’interventions d’entraıˆnement a` l’effort et,
par conse´quent, ame´liorer leur condition physique avant la
chirurgie (c’est-a`-dire, pre´adaptation). L’impact de telles
interventions sur les re´sultats cliniques reste incertain.
Conclusions Le CPET pe´riope´ratoire connaıˆt une plage
croissante d’utilisations, notamment pour l’e´valuation du
risque, la prise de de´cision collaborative, les soins
personnalise´s, l’e´valuation du be´ne´fice des interventions
et le guidage de la prescription de pre´adaptation. Ces
indications sont potentiellement importantes pour les
patients devant subir une chirurgie dans le cadre d’un
programme de RRAC, mais il n’y a actuellement que peu
de publications portant spe´cifiquement sur le CPET dans le
contexte de programmes de RRAC.
Cardiopulmonary exercise testing (CPET) has an
established role in the evaluation of perioperative risk in
a range of types of surgery. Early work focused on heart
transplant and lung resection surgery.1-3 Recently, the
majority of studies have focused on major intra-abdominal
surgery.4-7 The way in which data derived from CPET have
been used has evolved over time. Initially, the focus was on
guiding clinician decisions about whether to undertake
surgery and where to care for patients following surgery
(intensive care unit [ICU] or general ward) as well as
identifying previously unsuspected comorbidity. Over
time, the focus has broadened to encompass contributing
to collaborative decision-making between patients and
clinicians,8 evaluating the consequences of neoadjuvant
therapies (including chemo- and radio-therapy), and
guiding prehabilitation (prehab) programs.
Enhanced Recovery after Surgery (ERAS) programs
have evolved over the past two decades from an enthusiast-
led clinical innovation9 to national implementation.10 A
typical ERAS care pathway incorporates pre- intra- and
postoperative elements, and implementation of such
pathways has been shown to reduce duration of hospital
stay with no increase in readmission rate.11 The relative
contribution of each element to the observed benefit is, in
general, uncertain. Early mobilization and feeding are the
elements most consistently associated with reduced
hospital stay.11 Overall, increased adherence to ERAS
elements seems to be associated with reduced length of
stay.11 Key preoperative elements include careful
evaluation of risk and management of patient
expectations. Cardiopulmonary exercise testing has the
potential to contribute to these elements as well as to
evaluate the consequences of novel perioperative
interventions of relevance to patients within ERAS
programs, including anti-cancer treatments (e.g.,
neoadjuvant chemotherapy) and exercise training (prehab).
The aim of this article is to explore the role of CPET and
prehab in patients undergoing surgery within an ERAS
program. To achieve this aim, we conducted two
systematic searches of Ovid MEDLINE (1946-present,
including in-process and daily update). To identify studies
addressing ERAS, we used the search terms ‘‘enhanced
recovery’’ or ‘‘ERAS’’ or ‘‘fast track’’ and ‘‘surgery’’.11 To
identify studies using CPET in the context of ERAS, this
ERAS search was combined with the search terms ‘‘CPET’’
or ‘‘CPX’’ or ‘‘cardiopulmonary exercise testing’’ or
‘‘exercise testing’’ or ‘‘CPEX’’ or ‘‘ _VO2max’’ and
‘‘surgery’’.12 To identify studies using prehab in the
context of ERAS, this ERAS search was combined with
the search terms ‘‘prehabilitation’’ or ‘‘prehab’’ or
‘‘exercise training’’ or ‘‘training’’ or ‘‘exercise therapy’’
or ‘‘exercise program’’ or ‘‘exercise intervention’’ or
‘‘physical training’’.13
The search of CPET in ERAS identified one consensus
statement in the British Medical Journal discussing the
potential benefit of CPET in preoperative assessment for
ERAS but no primary reports of studies.14 The search of
prehabilitation in ERAS programs identified two narrative
reviews15,16 but no specific studies. Some recent studies
from the UK (including from our own group)17,18 evaluate
CPET within the context of an ERAS program but do not
explicitly report that patient care was ERAS-based. This
has occurred, in part, as a consequence of the national
implementation of the Enhanced Recovery Partnership
Program10,14 within the National Health Service (NHS) in
the UK from 2009 to 2011, which resulted in widespread
adoption of ERAS programs across most NHS trusts for a
range of common elective surgeries (colorectal, urology,
gynecology, lower limb joint replacements).
Given the paucity of primary clinical studies in the
context of ERAS, we subsequently conducted a secondary
search to explore the roles of CPET and prehabilitation in
patients undergoing surgery irrespective of whether this
was in the context of an ERAS program. Where examples
from ERAS are available, we have highlighted this;
however, much of the content of this review is based on
extrapolating from the surgical literature in general. To
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give context to this literature, we have added an
introductory section summarizing the substantial general
literature exploring the relationship between physical
fitness, physical exercise, and health outcomes as well as
describing the physiology and conduct of CPET.
Physical activity, exercise, and health outcomes
There is a large body of evidence supporting the notion that
physical fitness has benefits in almost every context of
health and disease19,20 and, furthermore, that physical
inactivity is one of the leading public health issues facing
our generation.21,22 For example, better outcomes for fitter
or more active patients have been documented in coronary
artery disease,23,24 heart failure,25-27 hypertension,28
diabetes,29,30 chronic obstructive pulmonary disease
(COPD),31 depression,32 dementia,33 chronic kidney
disease,34 cancer,35 and stroke.36,37 It has also been
shown that physical activity reduces the risk of chronic
diseases, including type 2 diabetes,38 osteoporosis,39
obesity,40 depression,41 and cancer of the breast,42
kidney,43 and colon.24 Although the instantaneous risk of
death may be increased during physical activity or
training,23,44 the cumulative benefit of regular physical
activity and/or exercise outweighs this relatively short-
lived period of elevated risk.24
Such data raise the obvious hypothesis: can health
outcomes be improved by intervening to improve physical
fitness? Where data are available, it is generally true that
public health promotion of physical activity is effective.45
Moreover, exercise interventions in the form of supervised
and unsupervised training programs have been shown to be
beneficial in a variety of conditions, including COPD,
stroke, heart failure, and intermittent claudication,46-50
although the long-term benefits of such interventions are
less well evaluated.
Perioperative cardiopulmonary exercise testing
Cardiopulmonary exercise testing provides an objective
method of evaluating exercise capacity (functional reserve
or physical fitness). Furthermore, it allows interrogation of the
causes of exercise intolerance when exercise capacity is
reduced. Cardiopulmonary exercise testing integrates expired
gas analysis (oxygen and carbon dioxide concentrations) with
the measurement of ventilatory flow, thereby enabling
calculation of oxygen uptake ( _VO2) and carbon dioxide
production ( _VCO2) under conditions of varying physiological
stress imposed by a range of defined external workloads.
Heart rate, oxygen saturations, blood pressure, and
electrocardiogram can also be monitored simultaneously
with expired gas analysis. Thus, CPET provides a global
assessment of the integrated responses of the pulmonary,
cardiovascular, hematological, and metabolic systems that
are not adequately reflected through measuring how
individual organ systems function at rest.51
The modes of exercise commonly employed in CPET
include cycle ergometry and treadmill, while arm crank
ergometry is used occasionally. In the perioperative setting,
most groups have utilized cycle ergometry, and this has
several advantages over the treadmill. Most importantly,
cycle ergometry allows accurate determination of the
external work rate and thus evaluation of the _VO2-work
rate relationship, which is difficult with a treadmill. In
addition, cycle ergometry also requires less skill than a
treadmill (i.e., performance is consequently less affected by
practice); it is cheaper and takes up less space.52
A variety of exercise protocols can be used during CPET
(e.g., incremental tests, constant work rate tests) in order to
interrogate different elements of the exercise response. In
the perioperative context, the continuous incremental
exercise test (incremental ramp test) to the limit of
tolerance (symptom limited) has been used most
widely.53 The advantages of this exercise protocol are as
follows:
1. It evaluates the exercise response across the entire
range of functional capacity.
2. It allows assessment of the normalcy or otherwise of
the exercise response.
3. It permits identification of the site of functional
exercise limitation.
4. It gives an appropriate frame of reference for training
or rehabilitation targets.
5. The initial work rate is low and there is a short
duration of high intensity exercise.
6. The entire protocol is of short duration – eight to
twelve minutes of exercise.
A typical test profile includes three minutes of resting
measurement, followed by three minutes of unloaded
cycling (cycling against no resistance), and then a
continuously increasing ramp until exhaustion. The
gradient of the ramp is selected to achieve a test duration
of eight to twelve minutes. In addition, gas exchange data
may be collected in recovery, typically for five minutes.
In the early days of perioperative CPET, some groups
initially stopped tests above the anaerobic threshold (AT)
but before symptom limitation because of safety concerns
in this previously unevaluated population.4,6 Nevertheless,
subsequent review of the safety studies of CPET has
revealed a mortality rate of approximately two to five per
100,000 in patient populations that include patients
undergoing lung and heart transplant.51,54 Consequently,
symptom limited tests are now most commonly employed.
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The measurements made during an incremental exercise
test are summarized in Table 1. The output from
incremental CPET is by convention represented
graphically in a nine-panel plot.51,52 Exercise capacity
can be evaluated and causes of exercise limitation can be
identified as patterns of abnormality in these plots.
Exercise capacity (functional capacity or physical
fitness) can be described by the AT and _VO2peak:These
variables are metabolic rates that are expressed in
millilitres of _VO2 per minute absolute, or indexed to
bodyweight, or as percentages of predicted values. The
term _VO2peak is defined as the highest oxygen uptake
recorded during an incremental exercise test at the point of
symptom limitation. The anaerobic threshold (also known
as the lactate threshold, ventilatory threshold, gas exchange
threshold, or lactic acidosis threshold) is considered to be a
descriptor of exercise capacity that characterizes the upper
limits of exercise intensities that can be accomplished
almost wholly aerobically.51 Below the AT, exercise can be
sustained almost indefinitely, whereas above the AT,
progressive increases in work rate result in progressive
reductions in exercise tolerance.55 The AT is defined as the
_VO2 at which there is a transition from a phase of no
increase, or only a small increase in arterial [lactate], to a
phase of rapidly accelerating increase in arterial [lactate]
associated with a progressive metabolic acidosis.56 This
point can be estimated noninvasively by breath-by-breath
expired gas analysis during CPET.57 The onset of
metabolic acidosis at the AT is accompanied by a rise in
the pulmonary CO2 output ( _VCO2) resulting from the
intramuscular and blood buffering by bicarbonate of
lactate-associated protons.58,59 This can be identified
during incremental exercise testing as a change in the
gradient of the _VCO2- _VO2 relationship (V-slope method
57
or modified V-slope method),60 typically accompanied by a
systematic rise in the ventilatory equivalent for oxygen
( _VE/ _VO2) and in end-tidal PO2 (PETO2) without a
concomitant decrease in end-tidal PCO2 (PETCO2) or
increase in the ventilatory equivalent for CO2 ( _VE/ _VCO2)
(ventilatory equivalents method).61 Several investigators
have shown that these indirect approaches provide a valid
estimate of the lactic acid threshold (LaT) both in healthy
volunteers and in patients with cardiac disease and
COPD.62-65
The ratio of ventilation _VE to _VO2 is the ventilatory
equivalent for oxygen ( _VE/ _VO2), and the ratio of _VE to
_VCO2 is the ventilatory equivalent for carbon dioxide ( _VE/
_VCO2). The ventilatory equivalents for both O2 and CO2
are related to the ratio of pulmonary dead space to tidal
volume (Vd/Vt) and increase as dead space increases
(although they also increase with hyperventilation).
Abnormally high ventilatory equivalents are thus evident
in any pathological condition with increased dead space,
e.g., COPD, pulmonary fibrosis, heart failure, and
pulmonary embolic disease.
In summary, the incremental exercise test to the limit of
tolerance using cycle ergometry (incremental ramp test)
has been used extensively in both clinical practice and
clinical trials. It permits the accurate determination of
exercise capacity and also allows the identification of the
site of exercise limitation when this is abnormal. The AT
and _VO2peak;which are determined from this test, are
validated measures of exercise capacity and are the
appropriate variables to use to describe physical fitness in
clinical practice and research trials. The efficacy of
exercise training programs (prehab or otherwise) can be
evaluated using the incremental exercise test. Effective
training would be expected to cause an increase in the AT
and/or _VO2peak:These variables can be measured reliably
and can thus be used to compare patient groups from
different clinical centres and compare outcomes in clinical
trials.
Cardiopulmonary exercise testing-derived variables
and perioperative outcomes
The hypothesis that unfit patients are more susceptible to
adverse outcomes following major surgery is intuitively
appealing and implicit in many aspects of preoperative
Table 1 Measurements and variables collected during CPET
Measurement Variables Symbol
External work Work rate WR
Exercise capacity Peak oxygen uptake _VO2peak
Anaerobic threshold AT
Metabolic gas
exchange
Oxygen uptake _VO2
Carbon dioxide production _VCO2
Respiratory Exchange Ratio RER
Ventilatory Minute Ventilation _VE
Tidal Volume VT
Respiratory Rate RR
Pulmonary gas
exchange
Ventilatory equivalents for CO2 _VE/ _VCO2
Ventilatory equivalents for O2 _VE/ _VO2
End-tidal Oxygen PETO2
End-tidal CO2 PETCO2
Oxygen saturations SpO2
Cardiovascular Heart rate HR
Blood pressure NIBP
Oxygen pulse _VO2/HR
Symptoms dyspnea, fatigue, chest
pain, leg pain
CPET = Cardiopulmonary exercise testing
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assessment. For example, the ability to climb stairs or
walk to the local shops is often used as a clinical indicator
of functional capacity during preoperative assessment.
During the late 1980s and early 1990s, Paul Older et al. in
Melbourne, Australia published novel research using
CPET in preoperative assessment. In 1993, they reported
preoperative CPET data on 184 patients undergoing
elective major surgery and reported that a lower AT was
associated with elevated mortality following surgery.66 To
date, 24 cohort studies (including over 4,000 patients)
have reported the relationship between preoperative
CPET-derived variables and postoperative outcome (see
Table 2 for details). These data have been brought
together in several systematic reviews12,67,68 that, in
summary, show a remarkably consistent relationship
between physical fitness – defined using CPET-derived
variables – and postoperative outcome. The few studies
that do not find a statistically significant relationship are
small and underpowered. Indeed, all studies evaluating
more than 100 patients report a statistically significant
relationship with outcome. A limitation of this literature is
the fact that, in most studies, clinicians were not blinded to
the CPET results and so used them to make clinical
decisions such as the elective utilization of critical care
facilities. This confounding by indication introduces
uncertainty as to the true strength of the relationship
between fitness and surgical outcome.69 The effect of such
confounding would be to reduce the strength of
association reported in the literature, since clinicians
would be likely to respond to high-risk tests by
instituting management to reduce risk, thereby diluting
the strength of the association between risk and outcome.
The limited available blinded data5,18 reports a stronger
association between risk and outcome than the potentially
confounded data6 supporting the notion of confounding by
indication. An additional value of CPET that is less
amenable to evaluation in clinical trials is the opportunity
to identify unsuspected comorbidities such as ischemic
heart disease (e.g., a flat oxygen pulse, electrocardiogram
changes or arrhythmias,66,70 and pulmonary hypertension,
which we have correctly identified in a handful of cases in
our own practice).71-73
The use of CPET in the perioperative setting has increased
rapidly in the UK over the last decade. Survey data from the
UK suggest that the number of hospitals using CPET for
evaluation of perioperative risk has risen from 17% in 200874
to 32% in 2011,75 and anecdotally, it is probably 40-50% in
2014. In general, perioperative CPET tests were requested by
surgeons or anesthetists and conducted by anesthetists, but
clinical arrangements varied across institutions. Adoption in
other countries is not documented, but anecdotally, it is at a
much lower level then in the UK.
Complex risk stratification
Recent data have extended previous work in a number of
ways, including the use of multiple CPET-derived
variables to construct predictive models, exploration of
the prediction of longer-term outcomes, as well as the
comparison and combination of CPET with other candidate
risk predictors.
Colson et al. reported data on 1,725 patients undergoing
elective major surgery in a single institution in Australia
with 36% mortality in this cohort at five years. While no
single variable was significantly predictive of long-term
outcome, a model incorporating four physiological
variables measured at the AT predicted five-year
mortality.76 These data are intriguing because of both the
prediction of a longer-term mortality and the use of a
multivariable approach. It is unclear whether this model
will be generalizable to other settings.
Carlisle et al. showed improved prediction of mortality
following abdominal aortic aneurysm surgery when CPET-
derived variables were used in combination with a clinical
risk score, i.e., the revised cardiac risk index (‘‘Lee score’’),
in comparison with CPET variables alone.77 James et al.
showed better prediction of major adverse cardiac events
and all complications using CPET-derived variables when
compared with plasma biomarkers.78 They did not evaluate
the performance of the different variables used in
combination.
Using risk information
The majority of the perioperative CPET literature has
focused on the use of CPET-derived information to guide
clinicians’ decision-making. This has included choice of
procedure and perioperative care environment. Patients
defined as high-risk for adverse outcomes following
surgery may be scheduled for less physiologically
challenging procedures. For example, a defunctioning
colostomy and palliative resection may be chosen instead
of a more definitive tumour resection. The rationale for this
approach is that the balance between risk and benefit for
the procedure is specific to an individual, and the risks of
major procedures for patients with the highest level of risk
may outweigh any possible benefits. More commonly,
CPET data have been used to guide the choice of
postoperative care.4 In the context of enhanced recovery
where the focus is on early mobilization and rapid
normalization of physiological function, this may be
viewed from the converse perspective of identifying low-
risk patients who are safe to triage to enhanced recovery
care on a normal ward.
Cardiopulmonary exercise testing and ERAS 135
123
T
a
b
le
2
C
o
h
o
rt
st
u
d
ie
s
re
p
o
rt
in
g
th
e
re
la
ti
o
n
sh
ip
b
et
w
ee
n
ex
er
ci
se
ca
p
ac
it
y
v
ar
ia
b
le
s
an
d
p
o
st
o
p
er
at
iv
e
o
u
tc
o
m
e
A
u
th
o
r,
Y
ea
r,
Jo
u
rn
al
P
at
ie
n
ts
n
D
es
ig
n
A
T
A
ss
o
ci
at
io
n
&
R
is
k
T
h
re
sh
o
ld
(m
L
kg
-
1
m
in
-
1
)
V
O
2
P
ea
k
A
ss
o
ci
at
io
n
&
R
is
k
T
h
re
sh
o
ld
(m
L
kg
-
1
m
in
-
1
)
V
E
/V
C
O
2
O
u
tc
o
m
e
O
ld
er
1
9
9
3
C
h
es
t
M
aj
o
r
A
b
d
o
m
1
8
7
Y
\
1
1
S
u
b
m
ax
im
al
te
st
s
n
o
t
m
ea
su
re
d
Y
C
V
S
M
o
rt
al
it
y
O
ld
er
1
9
9
9
C
h
es
t
M
aj
o
r
A
b
d
o
m
5
4
8
Y
\
1
1
S
u
b
m
ax
im
al
te
st
s
n
o
t
m
ea
su
re
d
-
M
o
rt
al
it
y
W
il
so
n
2
0
1
0
B
JA
M
aj
o
r
A
b
d
o
m
8
4
7
Y
\
1
0
.9
S
u
b
m
ax
im
al
te
st
s
n
o
t
m
ea
su
re
d
Y
[
3
4
M
o
rt
al
it
y
S
n
o
w
d
en
2
0
1
0
A
n
n
S
u
rg
M
aj
o
r
A
b
d
o
m
1
1
6
B
li
n
d
ed
Y
\
1
0
.1
Y
N
M
o
rb
id
it
y
–
D
7
P
O
M
S
H
ig
h
to
w
er
2
0
1
0
B
JA
M
aj
o
r
A
b
d
o
m
3
2
B
li
n
d
ed
Y
N
N
M
o
rb
id
it
y
W
es
t
2
0
1
4
B
JA
C
o
lo
n
1
3
6
B
li
n
d
ed
Y
\
1
0
.1
Y
\
1
6
.7
Y
M
o
rb
id
it
y
–
D
5
P
O
M
S
W
es
t
2
0
1
4
B
JS
R
ec
ta
l
1
0
5
B
li
n
d
ed
Y
\
1
0
.6
Y
\
1
8
.6
-
M
o
rb
id
it
y
–
D
5
P
O
M
S
P
re
n
ti
s
2
0
1
3
B
JU
C
y
st
ec
to
m
y
8
2
B
li
n
d
ed
Y
\
1
2
Y
-
M
o
rb
id
it
y
–
C
la
v
ie
n
-D
in
d
o
;
L
O
S
N
u
g
en
t
1
9
9
8
Ir
i.
M
ed
A
A
A
3
0
N
N
-
M
o
rt
al
it
y
an
d
co
m
p
li
ca
ti
o
n
s
H
ar
te
ly
2
0
1
2
B
JS
A
A
A
4
1
5
2
ce
n
tr
es
Y
\
1
0
.2
Y
\
1
5
Y
M
o
rt
al
it
y
P
re
n
ti
s
2
0
1
2
J
V
a
s
S
u
rg
A
A
A
1
8
5
B
li
n
d
ed
Y
\
1
0
Y
-
L
O
S
,
M
o
rb
id
it
y
;
IC
U
L
O
S
G
o
o
d
y
ea
r
2
0
1
3
P
er
io
p
M
A
A
A
2
3
0
Y
\
1
1
-
-
M
o
rt
al
it
y
,
L
O
S
,
C
o
st
C
ar
li
sl
e
2
0
0
7
B
JS
A
A
A
1
3
0
Y
Y
[
4
2
M
o
rt
al
it
y
S
n
o
w
d
en
2
0
1
3
A
n
n
o
f
S
u
rg
M
aj
o
r
H
ep
at
o
b
il
ia
ry
3
8
9
B
li
n
d
ed
Y
Y
Y
M
o
rt
al
it
y
,
L
O
S
Ju
n
ej
o
2
0
1
2
B
JS
H
ep
at
ic
re
se
ct
io
n
1
3
1
Y
\
9
.9
M
o
rt
al
it
y
Y
[
3
4
.5
M
o
rt
al
it
y
,
M
o
rb
id
it
y
A
u
sa
n
ia
2
0
1
2
B
JS
W
h
ip
p
le
’s
1
2
4
B
li
n
d
ed
Y
\
1
0
.1
Y
Y
M
o
rb
id
it
y
,
M
o
rt
al
it
y
,
P
an
cr
ea
ti
c
L
ea
k
E
p
st
ei
n
2
0
0
4
L
iv
er
T
ra
n
sp
L
iv
er
T
ra
n
sp
la
n
ts
5
9
Y
\
6
0
%
p
re
d
ic
te
d
Y
\
6
0
%
p
re
d
ic
te
d
-
M
o
rt
al
it
y
P
re
n
ti
s
2
0
1
2
L
iv
er
T
ra
n
sp
L
iv
er
T
ra
n
sp
la
n
ts
1
6
5
B
li
n
d
ed
Y
\
9
Y
Y
M
o
rt
al
it
y
,
L
O
S
B
er
n
al
2
0
1
4
L
iv
er
T
ra
n
sp
L
iv
er
T
ra
n
sp
la
n
ts
3
9
9
Y
Y
-
M
o
rt
al
it
y
,
L
O
S
N
ag
am
at
su
1
9
9
4
N
ih
o
n
K
yo
u
U
p
p
er
G
I
5
2
-
Y
-
C
ar
d
io
p
u
lm
o
n
ar
y
M
o
rb
id
it
y
N
ag
am
at
su
2
0
0
1
J
T
h
o
r
&
C
V
U
p
p
er
G
I
9
1
N
Y
-
C
ar
d
io
p
u
lm
o
n
ar
y
M
o
rb
id
it
y
F
o
rs
h
aw
2
0
0
8
A
n
n
T
h
o
r
S
u
rg
U
p
p
er
G
I
7
8
Y
Y
Y
C
ar
d
io
p
u
lm
o
n
ar
y
M
o
rb
id
it
y
N
N
N
N
o
n
ca
rd
io
p
u
lm
o
n
ar
y
m
o
rb
id
it
y
M
o
y
es
2
0
1
3
A
n
n
R
C
o
ll
S
u
rg
U
p
p
er
G
I
1
0
8
Y
\
9
Y
-
C
ar
d
io
p
u
lm
o
n
ar
y
M
o
rb
id
it
y
M
cC
u
ll
o
u
g
h
2
0
0
6
C
h
es
t
B
ar
ia
tr
ic
1
0
9
Y
Y
\
1
5
.6
-
M
o
rb
id
it
y
H
en
n
is
2
0
1
2
B
JA
B
ar
ia
tr
ic
1
0
6
Y
\
1
1
Y
Y
M
o
rb
id
it
y
P
O
M
S
D
5
Y
=
si
g
n
ifi
ca
n
t
as
so
ci
at
io
n
b
et
w
ee
n
v
ar
ia
b
le
an
d
p
o
st
o
p
er
at
iv
e
o
u
tc
o
m
e;
A
A
A
=
ab
d
o
m
in
al
ao
rt
ic
an
eu
ry
sm
;
A
b
d
o
m
=
ab
d
o
m
in
al
;
C
V
S
=
ca
rd
io
v
as
cu
la
r;
G
I
=
g
as
tr
o
in
te
st
in
al
;
N
=
n
o
si
g
n
ifi
ca
n
t
as
so
ci
at
io
n
b
et
w
ee
n
v
ar
ia
b
le
an
d
o
u
tc
o
m
e;
-
=
as
so
ci
at
io
n
b
et
w
ee
n
v
ar
ia
b
le
an
d
o
u
tc
o
m
e
n
o
t
re
p
o
rt
ed
;
P
O
M
S
=
p
o
st
o
p
er
at
iv
e
m
o
rb
id
it
y
sc
o
re
;9
6
C
la
v
ie
n
-D
in
d
o
=
cl
as
si
fi
ca
ti
o
n
o
f
su
rg
ic
al
co
m
p
li
ca
ti
o
n
s;
9
7
L
O
S
=
le
n
g
th
o
f
st
ay
;
IC
U
=
in
te
n
si
v
e
ca
re
u
n
it
;
_ V
O
2
p
ea
k
=
p
ea
k
o
x
y
g
en
u
p
ta
k
e;
_ V
E
/
_ V
C
O
2
=
v
en
ti
la
to
ry
eq
u
iv
al
en
ts
fo
r
C
O
2
136 D. Z. H. Levett, M. P. W. Grocott
123
Cardiopulmonary exercise testing-guided postoperative
care
Following their original study,66 Older et al. suggested that
CPET data might be useful to guide decisions about the
choice of postoperative care environment, with less fit
patients being allocated to an intensive care environment
following surgery.4 In a subsequent prospective study, the
same group used CPET-derived variables (AT, ventilatory
equivalents for oxygen, myocardial ischemia) along with
the magnitude of surgery to allocate patients to intensive
care, high dependency care, and ward care.4 None of the
patients allocated to ward care died from ‘‘cardiovascular’’
causes, and mortality in the high dependency unit and in
the ICU was lower than historical control data from the
same institution. This study is limited by the non-
randomized design and historical control data and by the
risk of bias in attributing the criteria for ‘‘cardiovascular’’
death (all-cause mortality was not reported).
While Older’s 1999 interventional study had several
limitations and therefore falls short of meeting modern
criteria for showing a causal link between the intervention
(postoperative care allocated by CPET-derived variables)
and outcome (postoperative morbidity and mortality), the
results are provocative and merit further investigation. A
pilot double-blind randomized controlled trial (RCT)
evaluating this has recently been completed in the UK.
The study enrolled 228 patients undergoing elective
colorectal cancer surgery within an ERAS program, and
results are expected early in 2015.79 Further studies
exploring the impact of CPET-guided intervention on
outcome are needed, but the complexity of evaluating such
a multifaceted intervention have so far limited the number
of investigators who have taken on this challenge. While
the literature is replete with manuscripts describing the
association between various preoperative markers of risk
and outcome, there is a lack of studies evaluating their
implementation using an experimental design.
Neoadjuvant therapy, physical fitness, and outcome
following surgery
Neoadjuvant therapy using chemotherapy (NAC) or
chemoradiotherapy (NACRT) is increasingly common
before major cancer surgery. The aim of this therapy is
to reduce tumour bulk prior to surgery and thereby increase
the likelihood of complete (or optimal) tumour clearance
and improve long-term outcome. Neoadjuvant therapy
using chemotherapy/NACRT is widely used in surgery for
gastric and esophageal cancer80 and for rectal cancer81 as
well as for breast,82 urology,83 lung84 and other tumour
types.
Two recently published studies explored the impact of
neoadjuvant therapy on physical fitness prior to major
surgery. The first study evaluated the effect of NAC on 89
patients with oesophageal or gastric cancer. Following
NAC, CPET-measured oxygen consumption was reduced
at the AT and peak exercise, and lower baseline values for
these variables were associated with increased one-year
mortality in patients who completed a full course of NAC
and underwent surgery.85 A subsequent study in 25 patients
undergoing NACRT prior to rectal cancer surgery within
an ERAS program reported similar results, with a fall in
oxygen consumption variables following NACRT but no
effect on mortality.86
It is currently unknown if the effects of neoadjuvant
immune therapies87 on physical fitness are similar to those
of NAC and NACRT.
Prehabilitation: exercise training before a physiological
challenge
Prehabilitation is defined as ‘‘the process of enhancing the
functional capacity of the individual to enable him or her to
withstand a stressful event’’.88,89 Physical exercise training
prior to elective surgery meets this criterion. It is well
documented that exercise training is feasible and safe in
patients with a spectrum of severe cardiac and pulmonary
disease. For example, physical exercise programmes have
been demonstrated to improve physical fitness and clinical
outcomes in patients with cardiac failure,47 ischemic heart
disease,90,91 and COPD50. Furthermore, patients on a
screening program for abdominal aortic aneurysm have
been shown to improve their physical fitness following a
moderate intensity exercise intervention scheduled three
times per week.92
In 2013, a systematic review of RCTs of aerobic
exercise training in elective intracavity surgery identified
ten studies with a total of 524 participants.13 Most of the
eligible publications reported small single-centre studies
describing feasibility and training efficacy. One eligible
study reported a significant difference in outcome. Arthur
et al. conducted an RCT of 246 patients undergoing cardiac
surgery and reported a one-day reduction in ICU and
hospital length of stay in the intervention group despite
finding no difference in exercise capacity between the
groups after eight weeks of aerobic interval training.93
Preliminary non-randomized data from patients
undergoing elective colorectal cancer surgery within an
ERAS program have shown the feasibility of providing a
CPET-guided structured responsive interval training
program that is delivered three times a week for six weeks
in a hospital setting after neoadjuvant chemoradiotherapy
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and before surgery.17 The control population was made up
of patients unable to engage with the exercise program for
logistical reasons (e.g., distance of residence from the
hospital). A follow-on randomized study is currently
evaluating the efficacy of a CPET-guided structured
responsive training program in maintaining physical fitness
after neoadjuvant chemoradiotherapy. The study population
are patients scheduled to undergo elective rectal cancer
surgery within an ERAS program.94 Importantly, the
neoadjuvant therapies, which are typically administered as
a course of therapy some weeks prior to surgery and
followed by a recovery period of six to 12 weeks or more,
have opened up a time window to train patients prior to
major cancer operations where previously the pressure of
reducing the time between diagnosis and surgery precluded
such an intervention.
Future directions
A number of opportunities are developing in perioperative
CPET, including increasingly sophisticated risk prediction,
collaborative decision-making, personalized medicine, and
targeted exercise interventions.
Risk prediction
Increasingly sophisticated risk prediction may be achieved
by using variables from CPET in combination with other
sources of data, such as clinical risk scores and plasma
biomarkers. In general, added predictive value would be
expected from unrelated but effective tests, and the very
limited available data are supportive of this notion.5,77
Furthermore, it seems likely that there will be an evolution
towards developing a hierarchy of tests to describe risk. For
example, simple clinical risk scores and screening
biomarkers may be used to screen out low-risk patients at
low cost. The remaining patients would, by definition, be of
uncertain or high risk and could be evaluated by a more
complex battery of tests so as to define their risk more
precisely and to identify specific limiting factors.
Cardiopulmonary exercise testing is likely to be of great
value in the second stage of this process.
Collaborative decision-making
Increasing recognition of the issue of ‘‘provider bias’’,
whereby patients tend to be offered surgery more often
when surgical capacity is generous in their local area, along
with a cultural swing towards patient empowerment have
driven the shared or collaborative decision-making agenda.
Rather than being used simply to guide a clinician’s choice
of care, risk data are now used to contribute to a discussion
between patient and clinician about the best course of
action for that patient. The aim of collaborative decision-
making is to provide patients with sufficient information to
allow them to decide on the most appropriate course of
treatment for their circumstances. Cardiopulmonary
exercise testing is of value in this process because it
provides risk information in a way that is intuitively easy to
comprehend – the idea of ‘‘fitness for surgery’’ is a good
basis for a discussion about the specific risks and benefits
of a particular procedure for a particular patient.
Evaluating perioperative therapies
The effect of neoadjuvant chemotherapy and
chemoradiotherapy on physical fitness and the consequent
adverse impact of these interventions on clinical outcomes
in less fit patients are likely to become of increasing
importance. Surgery for cancer, in particular, is now
commonly part of a complex set of interventions (e.g.,
NAC, NACRT, immunotherapy) directed against the
underlying pathology. The complex interactions between
these interventions are likely to alter the risk-benefit
equation for each treatment element for each patient. In
addition to the areas already highlighted in this review, the
impact of immunotherapies on physical fitness is unknown.
Furthermore, the effect of surgery on physical fitness and
the pattern of recovery postoperatively may be of
importance in the choice and timing of adjuvant
therapies. Cardiopulmonary exercise testing is a
candidate technology for evaluating the effects of
adjuvant therapies in isolation or in combination on
physical fitness, specifically identifying exercise
limitation caused by organ-specific harm.
Personalized medicine
Many of these themes are drawn together under the
heading of personalized or individualized medicine, i.e.,
the concept of giving the right treatment to the right patient
at the right time. The contribution of CPET to the
evaluation of perioperative risk is one example of this –
tailoring the choice of procedure and the perioperative care
to the individual patient’s risk. More sophisticated uses for
CPET may arise around neoadjuvant cancer therapies.
Variability in tumour response to treatment is potentially
amenable to prediction using information such as tumour
genome sequencing. Weighing such information against
CPET-derived data assessing the risk that neoadjuvant
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therapy will adversely impact physical fitness, it might be
possible to assess the likelihood of benefit and harm from a
specific neoadjuvant treatment for individual patients. This
information could be used to guide therapy, including the
selection of chemotherapy, the timing of chemotherapy in
relation to surgery, and the choice of an appropriate
prehabilitation program.
Exercise interventions
The use of CPET to define exercise training programs has
already been shown in a number of fields. It is likely that
such interventions will become increasingly sophisticated.
Prehabilitation approaches include endurance and strength
training, so-called high-intensity training schedules, and
the use of nutritional and pharmaceutical adjunctive
therapies to improve the efficacy of training stimuli.
Improved understanding of the optimal duration, pattern,
intensity, and qualities of such interventions will be needed
to maximize efficacy. In order to maximize the
effectiveness of training, we need a better understanding
of the complex interplay between adherence, efficacy, and
cost for in-hospital supervised training interventions vs
self-directed outpatient approaches.
Future clinical trials
While there is extensive evidence that exercise capacity
predicts adverse postoperative outcome, the case for
intervening to improve outcome on the basis of exercise
capacity is currently less clear. Further clinical trials are
required to evaluate the two most commonly promoted
clinical approaches based on exercise capacity data:
1. Altering the location and type of perioperative care to
reduce the risk of complications.
2. Exercise training programs to improve exercise
capacity prior to surgery – prehabilitation.
Trials are required: first, to establish that training
programs are effective in the surgical population and,
second, to ascertain that improved fitness translates to
improved outcome. Interrogation of the clinical trials
database identified 29 trials evaluating exercise testing in
surgical patients.95 The result of one RCT evaluating the
utility of CPET to direct perioperative care is expected
imminently.79 Twenty ongoing clinical trials are currently
evaluating the effect of prehabilitation training
interventions in a variety of surgical specialties, including
colorectal (seven trials), upper gastrointestinal (three
trials), and bariatric patients (one trial), abdominal aortic
aneurysm (one trial) urology (three trials), orthopedic (one
trial), and liver patients (two trials), general abdominal
(one trial), and coronary artery bypass grafting patients
(one trial). Thus, substantial new data should be
forthcoming in the near future.
Conclusions
While there is limited literature specific to CPET and
ERAS, the available data are consistent with the wider
literature on CPET and major surgery. Reduced physical
fitness (as defined by CPET variables) is associated with an
increased incidence of postoperative morbidity and
mortality. Information derived from CPET has been used
to guide both the choice of surgical procedure and the
postoperative care environment. Cardiopulmonary exercise
testing may also identify unsuspected comorbidities.
Recent developments include the increasing importance
of collaborative/shared decision-making, recognition of the
adverse impact of neoadjuvant therapies on physical fitness
(and possibly clinical outcome), and CPET-guided
prehabilitation.
Looking forward, CPET may have a role in increasing
the sophistication of the evaluation of preoperative risk
(hierarchical multivariable approach), in evaluating the
impact of a spectrum of neoadjuvant therapies, and in
guiding multimodal prehabilitation interventions.
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